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Abstract
Background: Exposure to environmental tobacco smoke (ETS), which contains potent
respiratory irritants, may lead to chronic airway inflammation and obstruction. Although ETS
exposure appears to cause asthma in children and adults, its role in causing COPD has received
limited attention in epidemiologic studies.
Methods: Using data from a population-based sample of 2,113 U.S. adults aged 55 to 75 years, we
examined the association between lifetime ETS exposure and the risk of developing COPD.
Participants were recruited from all 48 contiguous U.S. states by random digit dialing. Lifetime ETS
exposure was ascertained by structured telephone interview. We used a standard epidemiologic
approach to define COPD based on a self-reported physician diagnosis of chronic bronchitis,
emphysema, or COPD.
Results: Higher cumulative lifetime home and work exposure were associated with a greater risk
of COPD. The highest quartile of lifetime home ETS exposure was associated with a greater risk
of COPD, controlling for age, sex, race, personal smoking history, educational attainment, marital
status, and occupational exposure to vapors, gas, dusts, or fumes during the longest held job (OR
1.55; 95% CI 1.09 to 2.21). The highest quartile of lifetime workplace ETS exposure was also related
to a greater risk of COPD (OR 1.36; 95% CI 1.002 to 1.84). The population attributable fraction
was 11% for the highest quartile of home ETS exposure and 7% for work exposure.
Conclusion: ETS exposure may be an important cause of COPD. Consequently, public policies
aimed at preventing public smoking may reduce the burden of COPD-related death and disability,
both by reducing direct smoking and ETS exposure.
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COPD is a common disease, affecting 5–10% of the pop-
ulation of North America and Europe [1-3]. During the
past two decades, death and disability from COPD have
continued to increase worldwide [1,4]. Although direct
cigarette smoking is the major cause of COPD, up to two
cases out of ten cannot be explained solely by direct smok-
ing [5]. Environmental tobacco smoke (ETS) exposure,
which appears to cause new cases of asthma, could also
cause COPD [6-8]. Because it contains potent airway irri-
tants, ETS could lead to chronic airway irritation, inflam-
mation, and obstruction [6,9]. The role of ETS exposure in
causing COPD, however, has received limited attention in
epidemiologic studies [10,11]. Using data from a popula-
tion-based sample of U.S. adults, we examined the associ-
ation between lifetime ETS exposure and the risk of
developing COPD.
Methods
We used cross-sectional data from a cohort study of U.S.
adults to elucidate the impact of lifetime ETS exposure on
the risk of developing COPD. Initial recruitment and sur-
vey methods have been previously reported in detail [12].
The study was approved by the University of California,
San Francisco Committee on Human Research. Briefly,
2,113 adults aged 55 to 75 years were recruited by random
digit dialing among residents of the 48 contiguous U.S.
states with random over-sampling of geographic areas
that had the highest published COPD mortality rates [13].
The random "hot spot" sample was further enriched for
additional subjects with COPD. The overall study partici-
pation rate was 53% among households with an eligible
respondent present. Participants completed structured tel-
ephone interviews that included health history, work his-
tory, smoking, ETS exposure, and sociodemographic
characteristics.
We used the standard epidemiologic approach to define
COPD based on a self-reported physician diagnosis of
chronic bronchitis, emphysema, or COPD [1,14,15]. Dur-
ing the telephone interview, subjects were asked whether
they had ever received a physician's diagnosis of any of
several chronic respiratory conditions. Those who
reported physician diagnoses of chronic bronchitis or
emphysema were considered to have COPD, along with
those who specifically reported a physician diagnosis of
COPD. We included respondents with COPD who had
concomitant asthma because they clinically resemble per-
sons with COPD alone [16].
We obtained spirometry reports from the physicians of a
subgroup of 47 participants with COPD. The majority
(89%) had airflow obstruction, as indicated by a FEV1/
FVC ratio of less than 0.70 or an FEV1 less than 80% pre-
dicted. These physiologic data support the validity of our
case definition for COPD.
We ascertained lifetime cumulative ETS exposure at home
and work. Prenatal exposure was evaluated using the fol-
lowing survey item: "Did your mother smoke cigarettes
when she was pregnant with you before you were born?"
Subsequent home ETS exposure was assessed during
childhood and adolescence using the following survey
item: "Growing up until age 18, for how many years in
total did you live in the same household with someone
else who smoked tobacco products?" In addition, we
measured home ETS exposure during adulthood: "Since
age 18, for how many years in total have you lived in the
same household with someone else who smoked tobacco
products?" Cumulative lifetime home ETS exposure was
calculated using the sum of both home exposures in years.
Moreover, we ascertained cumulative lifetime work ETS
exposure using the following item: "Thinking about all of
the jobs you have had, for how many years of your
employment have you been regularly exposed to another
person's cigarette smoke inside your workplace?"
Direct personal cigarette smoking was evaluated using
standard questions from the National Health Interview
Survey [17]. Because workplace ETS exposure may be
higher in occupations that involve exposure to other air-
way irritants and particulates, we also ascertained occupa-
tional exposure to vapors, gas, dusts, or fumes during the
longest held job using a survey item developed for the
European Community Respiratory Health Survey [18].
Statistical analysis
Statistical analysis was conducted using SAS 8.2 (Cary,
NC). Bivariate analysis was conducted using the unpaired
t-test for continuous variables and likelihood ratio chi-
square test for dichotomous variables. We examined the
impact of lifelong cumulative ETS exposure and the risk of
COPD. Based on the distribution of cumulative ETS expo-
sure at home and work, we defined quartiles of exposure.
For lifetime work exposure, the first quartile was zero
years, so the first and second quartiles were collapsed as
the referent group (otherwise the first and second quartile
groups would both include zero values). We used logistic
regression analysis to examine the relationship between
each measure of ETS exposure and the risk of self-reported
COPD. We used multivariate logistic regression analysis
to control for factors that could confound the relation
between ETS exposure and COPD, including past smok-
ing history, age, sex, race-ethnicity, educational attain-
ment, marital status, and occupational exposure to VGDF
[12,19].
Consistent with the low prevalence of COPD among
never smokers, there were too few never smokers withPage 2 of 8
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address this issue, we controlled for the potential con-
founding effects of direct personal smoking in several
ways. In the primary strategy, we included a history of ever
smoking in the multivariate analysis. In an alternative
analysis, we controlled for current smoking and ex-smok-
ing as separate variables. There were no appreciable differ-
ences compared to primary analysis (this alternative
analysis is not reported). We also restricted the multivari-
ate analysis to subjects who reported no current smoking.
There were no substantive differences compared to the
primary analysis and these data are not reported. As an
additional alternative analysis, we controlled for cumula-
tive lifetime pack-years of smoking.
Both home and workplace ETS exposure independently
contribute to lifetime cumulative ETS exposure. Conse-
quently, workplace ETS exposure is not a confounder in
the putative pathway between home ETS exposure and the
development of COPD. Similarly, home ETS exposure
does not operate as a confounder in the relationship
between workplace ETS exposure and COPD onset. Based
on these considerations, we used separate logistic regres-
sion analysis models to examine cumulative lifetime
home and workplace ETS exposure, rather than including
both exposures in the same model. In a secondary analy-
sis, we examined home and work exposure in a mutually
adjusted model.
Prenatal ETS exposure, which occurs via the placental cir-
culation, may affect lung development and the subse-
quent risk of COPD by a different causal pathway than
postnatal ETS exposure [21,22]. In fact, prenatal ETS expo-
sure might be associated with both postnatal ETS expo-
sure and the risk of COPD, confounding the relationship
between postnatal ETS exposure and COPD. To address
this possibility, we conducted an additional analysis to
examine the independent relation between the two meas-
ures of cumulative lifetime ETS exposure (home and
work), taking prenatal ETS exposure into account.
We also examined whether prenatal ETS exposure, occu-
pational exposure to VGDF, or direct personal smoking
modified the association between home and work ETS
exposure and the risk of COPD. To accomplish this, inter-
action terms were evaluated in logistic regression models
that included main effects for ETS exposure, the potential
effect modifier, and personal smoking history. We evalu-
ated significant statistical interactions for evidence of syn-
ergism or antagonism on an additive scale, which is more
appropriate than a multiplicative scale for examining how
two factors might biologically interact to produce disease.
Using the odds ratio as an estimate of the relative risk, we
used the formula OR-1 to calculate the relative excess risk
[23,24]. If the relative excess risk for exposure to both fac-
tors together (e.g., direct smoking and ETS) is greater than
the sum of the relative excess risks of each factor alone
(e.g., smoking + ETS), a synergistic effect would be
present. If the relative excess risk for exposure to both fac-
tors is less than the sum of the relative excess risks of each
factor alone, antagonism would be present.
As a sensitivity analysis, we repeated the analysis using a
more restrictive definition of COPD that included only
those who specifically reported a diagnosis of emphysema
or COPD, excluding those with chronic bronchitis alone.
We used the method of Greenland and Drescher to esti-
mate the population attributable fraction from the multi-
variate logistic regression analysis controlling for personal
smoking, sociodemographic factors, and occupational
VGDF exposure [25]. This methodology provides a maxi-
mum likelihood estimator of the attributable fraction
from the logistic model.
Results
Subject characteristics
The prevalence of COPD was 18% among the cohort of
adults aged 55 to 75 years (95% CI 17 to 20%). Adults
with COPD were more likely to be female and unmarried;
they also had lower educational attainment than those
without COPD (Table 1). A greater proportion of adults
with COPD indicated ever smoking cigarettes compared
to other members of the general population (81% vs.
56%), with substantially more current smokers (33 vs.
16%).
ETS exposure
The prevalence of previous prenatal ETS exposure was
higher among adults with COPD than those without the
condition (8.3% vs. 5.6%, p = 0.051) (Table 2). Moreover,
the lifetime prevalence of any subsequent lifetime home
or workplace ETS exposure was higher among those with
COPD than among those without COPD (89% vs. 82%, p
= 0.0004 and 67% vs. 60%, p = 0.012, respectively). Per-
sons with COPD were also more likely to have a higher
cumulative lifetime exposure to ETS, with a greater pro-
portion of the COPD group having the highest quartile of
home and workplace exposure than those without the
condition (41% vs. 22% and 34% vs. 24%, respectively)
(Table 2).
ETS exposure and the risk of COPD
Maternal smoking during pregnancy was not statistically
associated with a higher risk of COPD, after controlling
for personal smoking and sociodemographic covariates
(OR 1.41; 95% CI 0.90 to 2.21) (Table 3). Higher cumu-
lative lifetime home and work exposure were, however,
related to a greater risk of developing COPD. The highest
quartile of home ETS exposure was associated with aPage 3 of 8
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highest quartile of workplace ETS exposure was also asso-
ciated with a higher risk of COPD (OR 1.60; 95% CI 1.20
to 2.14). After controlling for workplace VGDF exposure,
home and workplace ETS exposure remained associated
with the risk of COPD (OR 1.55; 95% CI 1.09 to 2.21 and
OR 1.36; 95% CI 1.002 to 1.84, respectively). Based on
this most adjusted analysis, the population attributable
fraction was 11% for the highest quartile of home ETS
exposure and 7% for work exposure.
We also examined the independent relationship between
cumulative lifetime ETS exposure and COPD, controlling
for prenatal ETS exposure. The highest quartiles of home
and workplace ETS exposure were associated with a
greater risk of COPD, controlling for personal smoking,
sociodemographic factors, occupational VGDF exposure,
and prenatal ETS exposure (OR 1.64; 95% CI 1.16 to 2.33
and OR 1.59; 95% CI 1.19 to 2.13, respectively).
There was no evidence that prenatal ETS modified the
relationship between ETS exposure and the risk of COPD
(p values for interaction with home ETS = 0.59 and work
ETS = 0.86). There was also no indication that occupa-
tional VGDF exposure modified the association between
ETS exposure at home or work and the risk of COPD (p for
interaction = 0.94 and 0.14, respectively).
There was evidence of a statistical interaction between
home ETS exposure and a history of ever smoking for the
risk of COPD (p = 0.041), whereas there was no interac-
tion for workplace ETS exposure (p = 0.17). The relative
excess risk for the highest quartile of home ETS exposure
among never smokers was 0.88. The relative excess risk for
Table 1: Personal characteristics in a population-based sample of 2,113 U.S. adults aged 55 to 75 years
Characteristic COPD (n = 386) No COPD (n = 1,727) P value
Age (years) 64.3 (6.2) 63.9 (6.1) 0.24
Gender (female) 246 (64%) 961 (56%) 0.004
Race-ethnicity (white) 337 (87%) 1495 (87%) 0.70
Married or cohabitating 186 (48%) 1080 (63%) <0.0001
Educational attainment <0.0001
High school degree 207 (54%) 709 (41%)
Some college 105 (27%) 529 (31%)
College or graduate degree 74 (19%) 489 (28%)
Cigarette smoking <0.0001
Current smoker 127 (33%) 279 (16%)
Past smoker 184 (48%) 685 (40%)
Never smoker 75 (19%) 763 (44%)
Proportions are column proportions (of those with and without COPD)
P-values from unpaired t-test (age) and likelihood ratio chi-square test
Table 2: Lifetime cumulative ETS exposure in a population-based sample of adults aged 55–75 years
Source of ETS exposure COPD (n = 386) No COPD (n = 1,727) P value
Prenatal ETS* 32 (8.3%) 96 (5.6%) 0.051
Cumulative lifetime home ETS <0.0001
Quartile 1 (0–9 yrs) 70 (18%) 443 (26%)
Quartile 2 (10–21 yrs) 72 (19%) 461 (27%)
Quartile 3 (22–41 yrs) 86 (22%) 451 (26%)
Quartile 4 (≥42 yrs) 158 (41%) 372 (22%)
Cumulative lifetime work ETS 0.0002
Quartile 1 & 2 (0–5 yrs)† 163 (42%) 881 (51%)
Quartile 3 (6–22 yrs) 93 (24%) 440 (25%)
Quartile 4 (≥23 yrs) 130 (34%) 406 (24%)
Proportions are column proportions (of those with and without COPD)
P-values from the likelihood ratio chi-square test
*Mother smoked during pregnancy
†First and second quartile were both zero, so they were combined into one group.Page 4 of 8
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exposure (i.e., first quartile) was 1.83. The relative excess
risk for combined high level home ETS exposure and per-
sonal smoking was 4.32, which exceeded the sum of the
relative excess risks for high level home ETS and personal
smoking (i.e., 4.32 > 0.88 + 1.83 or 4.32 > 2.71). These
results are consistent with a synergistic effect of home ETS
and smoking for COPD risk. In addition, these results
underscore the risk conferred by home ETS exposure
among never smokers (i.e., excess relative risk of 0.88).
ETS exposure and the risk of COPD – secondary analyses
In a secondary analysis, we controlled for personal direct
smoking history using cumulative lifetime pack-years of
smoking. The highest quartile of home and workplace
exposure were associated with a greater risk of COPD,
controlling for pack-years of personal smoking and socio-
demographic characteristics (OR 1.62; 95R CI 1.14 to
2.30 and OR 1.48; 95% CI 1.10 to 1.99, respectively).
After controlling for workplace VGDF exposure, home
and workplace ETS exposure were still related to a greater
risk of COPD (OR 1.49; 95% CI 1.04 to 2.12 and OR 1.24;
95% CI 0.91 to 1.69, respectively). In the latter analysis,
the confidence interval for workplace exposure widened
and did not exclude no relationship.
In other alternative analyses, we also examined lifetime
cumulative home and work ETS exposure in the same
model (mutually adjusted model). The highest quartile of
home (1.55; 95% CI 1.09 to 2.21) and workplace expo-
sure (OR 1.46; 95% CI 1.08 to 1.96) were associated with
a greater risk of COPD, controlling for smoking history
and sociodemographic characteristics.
Emphysema or COPD subgroup
In a sensitivity analysis, we examined the subgroup of
subjects who reported emphysema or COPD (n = 189),
excluding those who reported chronic bronchitis alone (n
= 194). Greater cumulative lifetime home and work ETS
exposure remained associated with a greater risk of COPD
after controlling for all covariates (OR 2.38 for highest
quartile; 95% CI 1.42 to 3.90 and OR 1.79; 95% CI 1.21
to 2.65).
Discussion
ETS exposure, both at home and work, was associated
with a greater risk of COPD in this population-based
study of older adults, even after taking personal smoking
history into account. On a population level, approxi-
mately 1 in 11 cases of COPD may be attributed, at least
in part, to home ETS exposure; 1 in 15 cases may be attrib-
utable to workplace ETS exposure.
Table 3: Lifetime cumulative ETS exposure and the risk of COPD in a population based sample of 2,113 U.S. adults aged 55 to 75 
years
Source of 
exposure
Level of exposure Risk of COPD 
(unadjusted)
Risk of COPD, 
controlling for 
smoking
Risk of COPD, 
controlling for 
smoking, 
sociodemographic 
indicators†
Risk of COPD, 
controlling for smoking, 
sociodemographic 
indicators, and 
workplace VGDF†
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Prenatal Mother smoked in pregnancy 1.54 (1.01 to 2.33) 1.32 (0.86 to 2.01) 1.41 (0.90 to 2.21) 1.36 (0.86 to 2.14)
Home 1st quartile (0–9 yrs) 1.0 (referent) 1.0 (referent) 1.0 (referent) 1.0 (referent)
2nd quartile (10–21 yrs) 0.99 (0.69 to 1.41) 0.88 (0.61 to 1.25) 0.92 (0.64 to 1.34) 0.90 (0.62 to 1.31)
3rd quartile (22–41 yrs) 1.21 (0.86 to 1.70) 0.95 (0.67 to 1.35) 0.95 (0.66 to 1.37) 0.94 (0.65 to 1.36)
4th quartile (≥42 yrs) 2.69 (1.97 to 3.68) 1.88 (1.35 to 2.61) 1.68 (1.19 to 2.38) 1.55 (1.09 to 2.21)
Work 1st & 2nd quartile (0–5 yrs)* 1.0 (referent) 1.0 (referent) 1.0 (referent) 1.0 (referent)
3rd quartile (6–22 yrs) 1.14 (0.86 to 1.51) 0.97 (0.73 to 1.30) 1.02 (0.76 to 1.38) 0.91 (0.67 to 1.24)
4th quartile (≥23 yrs) 1.73 (1.34 to 2.24) 1.34 (1.02 to 1.75) 1.60 (1.20 to 2.14) 1.36 (1.002 to 1.84)
VGDF = self-reported exposure to vapors, gas, dust, or fumes during longest held job
*First and second quartile were both zero, so they were combined as the referent group (otherwise both lower categories would include zero 
values)
†Multivariate logistic regression analysis controlling for age, sex, race, smoking history, educational attainment, and marital status. Each source of 
ETS exposure was evaluated in a separate logistic regression model.Page 5 of 8
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ports an association between ETS exposure and COPD. A
cross-sectional population-based study from Switzerland
found a relationship between self-reported ETS exposure
during the past 12 months and a higher risk of chronic
bronchitis symptoms [26]. A case-control study demon-
strated that self-reported ETS exposure was associated
with obstructive respiratory disease, defined as asthma,
chronic bronchitis, or emphysema [27]. Reports from the
Adventist Health Study of Smog (AHSMOG) indicated a
relationship between self-reported ETS exposure and a
greater risk of "airway obstructive disease" (asthma,
chronic bronchitis, or emphysema), chronic bronchitis
symptoms, and airway obstruction by pulmonary func-
tion testing [28,29]. These studies are limited by the lack
of a comprehensive and specific definition of COPD (i.e.,
includes chronic bronchitis, emphysema, and COPD but
not asthma), the absence of cumulative lifetime ETS expo-
sure data, and the omission of other occupational expo-
sures that could be correlated with ETS exposure.
The results suggest that home ETS exposure and personal
smoking may act synergistically to increase the risk of
COPD. There are several possible biological mechanisms
that could account for this synergistic action. ETS contains
potent respiratory irritants, such as formaldehyde and
acrolein, which could directly irritate the airways and
exacerbate smoking-related airflow obstruction. Both ETS
and direct smoking may increase airway permeability,
causing increased IgE levels and enhanced allergic sensiti-
zation to airborne antigens [30,31]. By this and other
mechanisms, ETS and cigarette smoking could act to
increase airway inflammation. Other possible mecha-
nisms are combined effects of smoking and ETS on bron-
chial hyperresponsiveness [32]. Further experimental
work will be necessary to elucidate the apparent synergy
between ETS exposure and direct smoking.
Our results suggest that the highest quartiles of home and
work ETS exposure were associated with a greater risk of
COPD. Is it therefore possible to conclude that lower lev-
els of ETS exposure are "safe" in terms of obstructive lung
disease? We believe that our data do not suggest a "safe"
level of ETS exposure. Based on our results, the 95% con-
fidence intervals for the lower exposure quartiles are com-
patible with a substantially increased risk of COPD.
Moreover, we have previously shown that very low levels
of ETS exposure can exacerbate adult asthma [33]. We
have also shown that moderate levels of ETS exposure are
associated with impaired pulmonary function [34]. Taken
together, these results indicate that even low-to-moderate
levels of ETS exposure may have deleterious effects on air-
way function and obstructive lung disease.
We used the standard epidemiologic definition of COPD,
based on a self-reported physician diagnosis of chronic
bronchitis, emphysema, or COPD [1,14,15]. This survey-
based approach enabled us to evaluate a population-
based sample of adults who resided throughout the conti-
nental United States, which ensured generalizable results.
On logistical grounds, conducting spirometry among sub-
jects who reside thousands of miles apart would be highly
difficult, if not impossible. The use of self-reported physi-
cian-diagnosis, however, may have resulted in some mis-
classification of disease status. Previous work indicated
that a similar survey-based definition of COPD had a high
positive predictive value (78%) when validated using a
blinded medical record review that included spirometry
and radiographic studies [35]. Other work confirmed that
a self-reported history of COPD is a strong predictor of air-
flow obstruction [36]. In the subset of our participants
with COPD who had available spirometry data, the prev-
alence of airflow obstruction was very high (89%). In
addition, the high prevalence of lifetime smoking in our
study, which was more than 80%, supports the diagnosis
of COPD. The prevalence of COPD in our sample (18%)
was also similar to that reported in two other population-
based studies conducted in the United States [1]. Further-
more, reanalysis of our data using a more restrictive defi-
nition of COPD that excluded chronic bronchitis did not
appreciably affect the results. In sum, misclassification of
COPD is not likely to bias our results; if present, such bias
would likely be non-differential with respect to ETS expo-
sure and reduce effect estimates towards the null value.
Lifetime cumulative ETS exposure was ascertained by self-
report, which could have resulted in exposure misclassifi-
cation. Previous studies have found moderate correlations
between self-reported ETS exposure and biomarker levels
(e.g., cotinine) or direct personal exposure monitoring
(e.g., nicotine) [33,37-42]. We cannot, however, exclude
some systematic misclassification of ETS exposure. For
example, persons with COPD, because they have respira-
tory symptoms, could be more likely to remember and
report ETS exposure, upwardly biasing the effect esti-
mates. Because our focus was on lifetime ETS exposure,
there is no other available ETS exposure methodology.
Cotinine level, the most widely used biomarker for ETS
exposure, reflects exposure during the past 1–2 days [42].
Direct exposure monitoring, such as the personal nicotine
badge, can only be used for brief periods of up to several
weeks [33,43]. Consequently, the only feasible method
for lifetime ETS exposure is survey-based.
Because smoking is the dominant risk factor for COPD,
we cannot completely exclude some residual confounding
by smoking. There were too few never smokers with
COPD (n = 75) to restrict the overall analysis to never
smokers. To address this issue, we controlled for personalPage 6 of 8
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smoking or current / past smoking. The multivariate anal-
ysis was also restricted to non-current smokers, yielding
essentially the same results. We also controlled for cumu-
lative lifetime pack-years of smoking in additional analy-
ses, which continued to show highly significant results for
home ETS exposure, but slightly attenuated findings for
workplace ETS after VGDF exposure was also controlled.
The interaction analysis also supported the elevated risk
for home ETS exposure among never smokers. In sum, the
results do not indicate that the results can be explained by
residual confounding by direct personal smoking history.
Conclusion
COPD is a leading cause of death and disability among
middle-aged adults in developed nations [1,4,44]. Adults
with COPD have a 10-fold higher risk of disability com-
pared to members of the general population [16].
Although cigarette smoking is the dominant cause of
COPD, other factors, such as occupational exposures,
appear to contribute to disease causation [12, 45]. Based
on our results, we believe that ETS exposure may also be
an important cause of COPD. Consequently, public poli-
cies aimed at preventing public smoking may reduce the
burden of COPD-related death and disability, both by
reducing direct smoking and ETS exposure.
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